Macular Hole Progression after Intravitreal Bevacizumab for Hemicentral Retinal Vein Occlusion
Macular edema secondary to retinal vein occlusion is commonly being treated with off-label intravitreal bevacizumab with good outcomes. A significant reduction in macular edema and improvement in visual acuity is seen following such a treatment with no serious adverse effects. In the reported case,...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | Case Reports in Ophthalmological Medicine |
| Online Access: | http://dx.doi.org/10.1155/2011/679751 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832563338507190272 |
|---|---|
| author | Manish Nagpal Vikram Mehta Kamal Nagpal |
| author_facet | Manish Nagpal Vikram Mehta Kamal Nagpal |
| author_sort | Manish Nagpal |
| collection | DOAJ |
| description | Macular edema secondary to retinal vein occlusion is commonly being treated with off-label intravitreal bevacizumab with good outcomes. A significant reduction in macular edema and improvement in visual acuity is seen following such a treatment with no serious adverse effects. In the reported case, a full-thickness macular hole was noticed one month after intravitreal bevacizumab for macular edema secondary to hemicentral retinal vein occlusion. On a detailed review of the pre- and postoptical coherence tomography scans, it was realized that there was a preexisting stage 2-3 macular hole which was masked by the hemorrhages and edema at the fovea and the macular hole had progressed following the injection. |
| format | Article |
| id | doaj-art-0f88c91af254420c9fa92f1e355ba4b6 |
| institution | Kabale University |
| issn | 2090-6722 2090-6730 |
| language | English |
| publishDate | 2011-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Ophthalmological Medicine |
| spelling | doaj-art-0f88c91af254420c9fa92f1e355ba4b62025-02-03T01:20:25ZengWileyCase Reports in Ophthalmological Medicine2090-67222090-67302011-01-01201110.1155/2011/679751679751Macular Hole Progression after Intravitreal Bevacizumab for Hemicentral Retinal Vein OcclusionManish Nagpal0Vikram Mehta1Kamal Nagpal2Department of Vitreo Retina, Retina Foundation, Shahibag, Gujarat, Ahmedabad 380004, IndiaDepartment of Vitreo Retina, Retina Foundation, Shahibag, Gujarat, Ahmedabad 380004, IndiaDepartment of Vitreo Retina, Retina Foundation, Shahibag, Gujarat, Ahmedabad 380004, IndiaMacular edema secondary to retinal vein occlusion is commonly being treated with off-label intravitreal bevacizumab with good outcomes. A significant reduction in macular edema and improvement in visual acuity is seen following such a treatment with no serious adverse effects. In the reported case, a full-thickness macular hole was noticed one month after intravitreal bevacizumab for macular edema secondary to hemicentral retinal vein occlusion. On a detailed review of the pre- and postoptical coherence tomography scans, it was realized that there was a preexisting stage 2-3 macular hole which was masked by the hemorrhages and edema at the fovea and the macular hole had progressed following the injection.http://dx.doi.org/10.1155/2011/679751 |
| spellingShingle | Manish Nagpal Vikram Mehta Kamal Nagpal Macular Hole Progression after Intravitreal Bevacizumab for Hemicentral Retinal Vein Occlusion Case Reports in Ophthalmological Medicine |
| title | Macular Hole Progression after Intravitreal Bevacizumab for Hemicentral Retinal Vein Occlusion |
| title_full | Macular Hole Progression after Intravitreal Bevacizumab for Hemicentral Retinal Vein Occlusion |
| title_fullStr | Macular Hole Progression after Intravitreal Bevacizumab for Hemicentral Retinal Vein Occlusion |
| title_full_unstemmed | Macular Hole Progression after Intravitreal Bevacizumab for Hemicentral Retinal Vein Occlusion |
| title_short | Macular Hole Progression after Intravitreal Bevacizumab for Hemicentral Retinal Vein Occlusion |
| title_sort | macular hole progression after intravitreal bevacizumab for hemicentral retinal vein occlusion |
| url | http://dx.doi.org/10.1155/2011/679751 |
| work_keys_str_mv | AT manishnagpal macularholeprogressionafterintravitrealbevacizumabforhemicentralretinalveinocclusion AT vikrammehta macularholeprogressionafterintravitrealbevacizumabforhemicentralretinalveinocclusion AT kamalnagpal macularholeprogressionafterintravitrealbevacizumabforhemicentralretinalveinocclusion |